Home » NEUROLOGIX SIGNS PACT WITH DIAMYD SUBSIDIARY ON PARKINSON'S THERAPY
NEUROLOGIX SIGNS PACT WITH DIAMYD SUBSIDIARY ON PARKINSON'S THERAPY
Neurologix, Inc.,
a biotech company committed to developing innovative gene therapies for the brain
and central nervous systems, has entered into a licensing agreement with a subsidiary
of Diamyd Medical, a biotechnology company based in Stockholm, Sweden, and Pittsburgh,
PA.
Pharmabiz
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May